U.S. Pharmaceutical Preparation Market. Analysis And Forecast to 2025
The report provides an in-depth analysis of the U.S. in-vitro diagnostic substance market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry.
In-vitro diagnostic substances
Abbott Diabetes Care, Orasure Technologies, Amag Pharmaceuticals, Streck, Diasorin Inc., Diadexus, Rapid Pathogen Screening, Maine Biotechnology Services, Saladax Biomedical, Corgenix Medical Corporation, George King Bio-Medical, Princeton Biomeditech Corp, Banyan Biomarkers, Anatech, Dxna LLC, CD Diagnostics, Akers Biosciences, Helica Biosystems, Green Mountain Antibodies, Biospacific, Innominata, Phase 2 Discovery, Immuno Concepts, Hepatochem, Lifecare Medical International, Horizon Diagnostic, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics, Horizon Diagnostic Inc, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics
In-vitro diagnostic substance market size;
In-vitro diagnostic substance production, value of shipments;
Key market players and their profiles;
Exports, imports and trade balance;
Import and export prices;
Forecast of the market dynamics in the medium term;
Key industry statistics;
Life cycle of the in-vitro diagnostic substance industry;
Number of establishments and their locations;
In-vitro diagnostic substance industry productivity.
Reasons to buy this report:
Take advantage of the latest data;
Find deeper insights into current market developments;
Discover vital success factors affecting the market.
Please note: The report will be provided within 3 working days after ordering.